An update on the relevance of vaccine research for the treatment of metastatic melanoma
{{output}}
Signal transduction inhibitors and anticheckpoint antibodies have significantly improved survival for metastatic melanoma patients, but most still die within 5 years. Vaccine approaches to induce immunity to well-characterized melanoma-associated antigens, or ... ...
